dacomitinib (vizimpro) Report issue

Small molecule Orphan Drug FDA Approved FDA Priority Review FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem

Back

Chemistry

Mol. Mass

469.95

ALogP

5.16

Rule of 5

No

Rule of 3

No
Details
  • SMILES: COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1
  • InChIKey: LVXJQMNHJWSHET-AATRIKPKSA-N
    InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+
  • Chirality: Achiral Molecule
  • Inorganic: No
  • Polymer: No

Sources

CHEMBL2110732   ChEMBL
dacomitinib *

CHEMBL2105719   ChEMBL
dacomitinib

2XJX250C20   NCATS
dacomitinib anhydrous *

Dacomitinib   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue